| 1 | twenty | 4,164 |
| 2 | thirty | 3,249 |
| 3 | forty | 2,727 |
| 4 | sixty | 2,630 |
| 5 | fifty | 2,234 |
| 6 | eighty | 1,355 |
| 7 | thirty-two | 984 |
| 8 | twenty-eight | 974 |
| 9 | twenty-six | 969 |
| 10 | seventy | 966 |
| 11 | ninety | 950 |
| 12 | thirty-six | 946 |
| 13 | forty-eight | 806 |
| 14 | forty-five | 784 |
| 15 | thirty-one | 777 |
| 16 | forty-two | 770 |
| 17 | thirty-five | 746 |
| 18 | thirty-four | 739 |
| 19 | thirty-three | 684 |
| 20 | forty-four | 675 |
| 21 | thirty-eight | 672 |
| 22 | forty-one | 664 |
| 23 | fifty-two | 630 |
| 24 | thirty-nine | 599 |
| 25 | forty-three | 582 |
| 26 | thirty-seven | 580 |
| 27 | forty-six | 573 |
| 28 | fifty-four | 531 |
| 29 | fifty-one | 513 |
| 30 | sixty-four | 503 |
| 31 | sixty-two | 501 |
| 32 | fifty-six | 496 |
| 33 | seventy-two | 487 |
| 34 | forty-seven | 486 |
| 35 | sixty-five | 470 |
| 36 | fifty-five | 469 |
| 37 | seventy-five | 468 |
| 38 | forty-nine | 457 |
| 39 | sixty-one | 441 |
| 40 | fifty-three | 435 |
| 41 | fifty-eight | 424 |
| 42 | sixty-eight | 422 |
| 43 | sixty-three | 415 |
| 44 | sixty-six | 409 |
| 45 | fifty-nine | 380 |
| 46 | fifty-seven | 375 |
| 47 | sixty-seven | 348 |
| 48 | seventy-four | 345 |
| 49 | seventy-one | 336 |
| 50 | eighty-five | 332 |
| 51 | ninety-six | 332 |
| 52 | eighty-four | 328 |
| 53 | ninety-two | 320 |
| 54 | sixty-nine | 319 |
| 55 | seventy-six | 318 |
| 56 | eighty-two | 313 |
| 57 | seventy-three | 312 |
| 58 | seventy-nine | 310 |
| 59 | eighty-one | 306 |
| 60 | eighty-six | 305 |
| 61 | ninety-four | 297 |
| 62 | seventy-eight | 291 |
| 63 | seventy-seven | 287 |
| 64 | eighty-eight | 279 |
| 65 | ninety-five | 266 |
| 66 | ninety-one | 265 |
| 67 | eighty-three | 254 |
| 68 | eighty-seven | 248 |
| 69 | ninety-three | 243 |
| 70 | ninety-eight | 239 |
| 71 | eighty-nine | 231 |
| 72 | ninety-seven | 227 |
| 73 | ninety-nine | 216 |
| 74 | fourty | 18 |
| 75 | ninty | 9 |
| 76 | fourty-four | 6 |
| 77 | fourty-nine | 6 |
| 78 | seven-week-old | 6 |
| 79 | anat | 5 |
| 80 | eight-one | 5 |
| 81 | placebo-using | 5 |
| 82 | sixty- | 5 |
| 83 | thirty- | 5 |
| 84 | 2489 | 4 |
| 85 | eight-five | 4 |
| 86 | eight-four | 4 |
| 87 | fourty-five | 4 |
| 88 | ninty-six | 4 |
| 89 | vilazodone-treated | 4 |
| 90 | 1,884 | 3 |
| 91 | 4303 | 3 |
| 92 | 6162 | 3 |
| 93 | 7601 | 3 |
| 94 | drug-addicted | 3 |
| 95 | fourty-six | 3 |
| 96 | implant-assigned | 3 |
| 97 | mhe-nl | 3 |
| 98 | nineteeen | 3 |
| 99 | ninty-seven | 3 |
| 100 | one-hundred-forty | 3 |
| 101 | one-hundred-ninety | 3 |
| 102 | permethrin-treated | 3 |
| 103 | ris-lai-treated | 3 |
| 104 | scytalidium | 3 |
| 105 | twenty- | 3 |
| 106 | 1,889 | 2 |
| 107 | 2,295 | 2 |
| 108 | 2552 | 2 |
| 109 | 29,217 | 2 |
| 110 | 2fg | 2 |
| 111 | 3,855 | 2 |
| 112 | 4154 | 2 |
| 113 | 47,369 | 2 |
| 114 | 5377 | 2 |
| 115 | 6,719 | 2 |
| 116 | 6698 | 2 |
| 117 | 7,741 | 2 |
| 118 | 7021 | 2 |
| 119 | 8181 | 2 |
| 120 | 9,488 | 2 |
| 121 | 9,592 | 2 |
| 122 | a2-incompatible | 2 |
| 123 | arvt-naive | 2 |
| 124 | belimumab-treated | 2 |
| 125 | eight-six | 2 |
| 126 | eight-three | 2 |
| 127 | eleven-week-old | 2 |
| 128 | eswl-treated | 2 |
| 129 | fifteen-month-old | 2 |
| 130 | fiftynine | 2 |
| 131 | forty- | 2 |
| 132 | fourty-seven | 2 |
| 133 | fourty-three | 2 |
| 134 | fully-branded | 2 |
| 135 | high-testosterone | 2 |
| 136 | lycopercisi | 2 |
| 137 | medication-preferring | 2 |
| 138 | moderate-cd/high-crp | 2 |
| 139 | one-hundred-and-eighty | 2 |
| 140 | one-hundred-and-one | 2 |
| 141 | one-hundred-and-ten | 2 |
| 142 | one-hundred-and-twenty | 2 |
| 143 | one-hundred-one | 2 |
| 144 | one-hundred-twenty-three | 2 |
| 145 | pain-vigilant | 2 |
| 146 | prior-cabg | 2 |
| 147 | thc-treated | 2 |
| 148 | thirteen-month-old | 2 |
| 149 | thirtyeight | 2 |
| 150 | twenty-bed | 2 |
| 151 | us-negative | 2 |
| 152 | 'cloud | 1 |
| 153 | -eighty | 1 |
| 154 | 1,124,897 | 1 |
| 155 | 1,8-2,4 | 1 |
| 156 | 1,866,951 | 1 |
| 157 | 10,665 | 1 |
| 158 | 10,856 | 1 |
| 159 | 10.213 | 1 |
| 160 | 100/192 | 1 |
| 161 | 100/312 | 1 |
| 162 | 10096 | 1 |
| 163 | 11,436 | 1 |
| 164 | 11,452 | 1 |
| 165 | 11,849 | 1 |
| 166 | 11,962 | 1 |
| 167 | 116/120 | 1 |
| 168 | 117,411 | 1 |
| 169 | 119,573 | 1 |
| 170 | 12,636 | 1 |
| 171 | 12,842 | 1 |
| 172 | 123/261 | 1 |
| 173 | 126,092 | 1 |
| 174 | 13,272 | 1 |
| 175 | 135,967 | 1 |
| 176 | 14,270 | 1 |
| 177 | 14/381 | 1 |
| 178 | 142+/-28 | 1 |
| 179 | 146,095 | 1 |
| 180 | 149,893 | 1 |
| 181 | 15,263 | 1 |
| 182 | 15,336 | 1 |
| 183 | 15,694 | 1 |
| 184 | 16,397 | 1 |
| 185 | 167343 | 1 |
| 186 | 169/176 | 1 |
| 187 | 169/227 | 1 |
| 188 | 17,065 | 1 |
| 189 | 17o | 1 |
| 190 | 18,254 | 1 |
| 191 | 187/303 | 1 |
| 192 | 18790 | 1 |
| 193 | 19.409 | 1 |
| 194 | 191,167 | 1 |
| 195 | 1‒12-year-old | 1 |
| 196 | 2,067,639 | 1 |
| 197 | 2,770 | 1 |
| 198 | 2,951.95 | 1 |
| 199 | 2/5738 | 1 |
| 200 | 204,699 | 1 |
| 201 | 206/250 | 1 |
| 202 | 209/212 | 1 |
| 203 | 21,004 | 1 |
| 204 | 21,524 | 1 |
| 205 | 21,692 | 1 |
| 206 | 2121/2292 | 1 |
| 207 | 219,088 | 1 |
| 208 | 22,156 | 1 |
| 209 | 22,214 | 1 |
| 210 | 22,216 | 1 |
| 211 | 234,331 | 1 |
| 212 | 24,037 | 1 |
| 213 | 24,959 | 1 |
| 214 | 247,831 | 1 |
| 215 | 25,180 | 1 |
| 216 | 253,238 | 1 |
| 217 | 254.78 | 1 |
| 218 | 25:50:25 | 1 |
| 219 | 26/235 | 1 |
| 220 | 267/890 | 1 |
| 221 | 29.0-42.4 | 1 |
| 222 | 2•8 | 1 |
| 223 | 3,633 | 1 |
| 224 | 3,809 | 1 |
| 225 | 30,528 | 1 |
| 226 | 30/244 | 1 |
| 227 | 30892 | 1 |
| 228 | 31,651 | 1 |
| 229 | 31,940 | 1 |
| 230 | 318/31 | 1 |
| 231 | 33,240 | 1 |
| 232 | 34,271 | 1 |
| 233 | 34/87 | 1 |
| 234 | 35,998 | 1 |
| 235 | 36,504 | 1 |
| 236 | 3824/4017 | 1 |
| 237 | 4-0.6 | 1 |
| 238 | 40/130 | 1 |
| 239 | 41/131 | 1 |
| 240 | 413-429 | 1 |
| 241 | 42,382 | 1 |
| 242 | 42,411 | 1 |
| 243 | 43,1 | 1 |
| 244 | 44.31 | 1 |
| 245 | 4429 | 1 |
| 246 | 46,685 | 1 |
| 247 | 46,769 | 1 |
| 248 | 47/130 | 1 |
| 249 | 471/666 | 1 |
| 250 | 476.29 | 1 |
| 251 | 478/1063 | 1 |
| 252 | 48,882 | 1 |
| 253 | 493,785 | 1 |
| 254 | 5,534 | 1 |
| 255 | 5-5 | 1 |
| 256 | 52,039 | 1 |
| 257 | 52,061 | 1 |
| 258 | 5294 | 1 |
| 259 | 53/57 | 1 |
| 260 | 5337 | 1 |
| 261 | 54540 | 1 |
| 262 | 5461 | 1 |
| 263 | 57,432 | 1 |
| 264 | 5893 | 1 |
| 265 | 6,827 | 1 |
| 266 | 6,987 | 1 |
| 267 | 60/88 | 1 |
| 268 | 63,251 | 1 |
| 269 | 63-wk-old | 1 |
| 270 | 6446 | 1 |
| 271 | 65,905 | 1 |
| 272 | 660/693 | 1 |
| 273 | 6891 | 1 |
| 274 | 7,538 | 1 |
| 275 | 7,629 | 1 |
| 276 | 7,661 | 1 |
| 277 | 7058 | 1 |
| 278 | 71,290 | 1 |
| 279 | 71,86 | 1 |
| 280 | 72,900 | 1 |
| 281 | 7487 | 1 |
| 282 | 75,242 | 1 |
| 283 | 75,589 | 1 |
| 284 | 7553 | 1 |
| 285 | 76,269 | 1 |
| 286 | 7607 | 1 |
| 287 | 78+/-16 | 1 |
| 288 | 7830 | 1 |
| 289 | 8,210 | 1 |
| 290 | 8,817 | 1 |
| 291 | 8.0/13.3 | 1 |
| 292 | 8139 | 1 |
| 293 | 8560 | 1 |
| 294 | 8688 | 1 |
| 295 | 890/2121 | 1 |
| 296 | 9,479 | 1 |
| 297 | 9,596 | 1 |
| 298 | 9274 | 1 |
| 299 | 9367 | 1 |
| 300 | 9408 | 1 |
| 301 | 9562 | 1 |
| 302 | ab103-treated | 1 |
| 303 | action-hf | 1 |
| 304 | ad-drug-naïve | 1 |
| 305 | adolescent/family | 1 |
| 306 | alvimopan-treated | 1 |
| 307 | among1036 | 1 |
| 308 | anastrozole-taking | 1 |
| 309 | anatabine-treated | 1 |
| 310 | animals-211 | 1 |
| 311 | animals-29 | 1 |
| 312 | animals-74 | 1 |
| 313 | animals-84 | 1 |
| 314 | arbidole-treated | 1 |
| 315 | aso-positive | 1 |
| 316 | b+e-treated | 1 |
| 317 | barangay | 1 |
| 318 | bardoxolone-methyl-treated | 1 |
| 319 | biflav | 1 |
| 320 | bk-viremic | 1 |
| 321 | blind-born | 1 |
| 322 | board-eligible/certified | 1 |
| 323 | bottom-integrated | 1 |
| 324 | brucella-negative | 1 |
| 325 | caelyx-treated | 1 |
| 326 | care-receiving | 1 |
| 327 | casein-treated | 1 |
| 328 | cbt-preferring | 1 |
| 329 | ce-dialyzed | 1 |
| 330 | chemotherapy-responding | 1 |
| 331 | chronotropically | 1 |
| 332 | cleaner-40 | 1 |
| 333 | clopidogrel-exposed | 1 |
| 334 | cohert | 1 |
| 335 | comparison-condition | 1 |
| 336 | conscription-aged | 1 |
| 337 | control-stented | 1 |
| 338 | control-supplemented | 1 |
| 339 | conventional-risk | 1 |
| 340 | cyclobenzaprine-treated | 1 |
| 341 | d350 | 1 |
| 342 | dawba-only | 1 |
| 343 | dc-vaccinated | 1 |
| 344 | dceas-treated | 1 |
| 345 | deferiprone-treated | 1 |
| 346 | dhea-deficient | 1 |
| 347 | diabesotensive | 1 |
| 348 | dissonance-intervention | 1 |
| 349 | dmt-naïve | 1 |
| 350 | do-not-intubate | 1 |
| 351 | dual-pathology | 1 |
| 352 | early-colonised | 1 |
| 353 | egfr+/er- | 1 |
| 354 | eight-nine | 1 |
| 355 | eight-seven | 1 |
| 356 | eightyeight | 1 |
| 357 | english/spanish-speaking | 1 |
| 358 | enty | 1 |
| 359 | eqt-treated | 1 |
| 360 | er2/er3 | 1 |
| 361 | ercp-naïve | 1 |
| 362 | ev68-positive | 1 |
| 363 | fcg-patient | 1 |
| 364 | ff7 | 1 |
| 365 | fifjty-two | 1 |
| 366 | fifteen-hundred | 1 |
| 367 | fiftyone | 1 |
| 368 | five-hundred-and-one | 1 |
| 369 | five/seven | 1 |
| 370 | forthy-three | 1 |
| 371 | forty-one-day-old | 1 |
| 372 | forty-seven-week-old | 1 |
| 373 | forty-year-old | 1 |
| 374 | fortythree | 1 |
| 375 | four-hundred-and-forty-five | 1 |
| 376 | four-hundred-forty-nine | 1 |
| 377 | four-hundred-twenty-four | 1 |
| 378 | fourteen-week-old | 1 |
| 379 | fourthy-eight | 1 |
| 380 | ga-only | 1 |
| 381 | gnrh-deficient | 1 |
| 382 | grintuss® | 1 |
| 383 | guanqiao | 1 |
| 384 | head-restrained | 1 |
| 385 | high-pm | 1 |
| 386 | high-qor | 1 |
| 387 | hiv/tb-coinfected | 1 |
| 388 | hmpv/rsv-coinfected | 1 |
| 389 | hospital-admitted | 1 |
| 390 | hour-to-hour | 1 |
| 391 | hundred-and-one | 1 |
| 392 | hypotonous | 1 |
| 393 | iai-treated | 1 |
| 394 | industry-reported | 1 |
| 395 | intensive-group | 1 |
| 396 | interferon-beta-1b-treated | 1 |
| 397 | intervention-fifty-six | 1 |
| 398 | intradermally-vaccinated | 1 |
| 399 | inulin-supplemented | 1 |
| 400 | irinotecan-naïve | 1 |
| 401 | irinotecan-treated | 1 |
| 402 | itchy/burning | 1 |
| 403 | khalil | 1 |
| 404 | laiv-experienced | 1 |
| 405 | lanthanum-treated | 1 |
| 406 | ll/tt | 1 |
| 407 | lohman | 1 |
| 408 | low-fluoroscopy | 1 |
| 409 | low-readiness | 1 |
| 410 | lower-numeracy | 1 |
| 411 | lvt-treated | 1 |
| 412 | ly2140023-treated | 1 |
| 413 | ly2196044-treated | 1 |
| 414 | maraviroc-receiving | 1 |
| 415 | med-assigned | 1 |
| 416 | method-among | 1 |
| 417 | milacemide-treated | 1 |
| 418 | more-disabled | 1 |
| 419 | mortalityin | 1 |
| 420 | mothod | 1 |
| 421 | n-acetylcysteine-assigned | 1 |
| 422 | nanohybrid-based | 1 |
| 423 | natamycintreated | 1 |
| 424 | neonaticide | 1 |
| 425 | never-hospitalized | 1 |
| 426 | niacin-er-treated | 1 |
| 427 | nighty | 1 |
| 428 | nine-hundred-ninety-one | 1 |
| 429 | nine-week-old | 1 |
| 430 | ninteen | 1 |
| 431 | nintey-five | 1 |
| 432 | ninty-eight | 1 |
| 433 | non-eating-disordered | 1 |
| 434 | non-european-born | 1 |
| 435 | non-hfi | 1 |
| 436 | nonabusing | 1 |
| 437 | nonhypersensitive | 1 |
| 438 | normotolerant | 1 |
| 439 | nsaid-using | 1 |
| 440 | octlar-treated | 1 |
| 441 | oligoasthenoteratospermic | 1 |
| 442 | on193 | 1 |
| 443 | one-hunderd-and-thirty-five | 1 |
| 444 | one-hundred- | 1 |
| 445 | one-hundred-and-fifty | 1 |
| 446 | one-hundred-and-fifty-seven | 1 |
| 447 | one-hundred-and-forty-nine | 1 |
| 448 | one-hundred-and-fourteen | 1 |
| 449 | one-hundred-and-seventeen | 1 |
| 450 | one-hundred-and-seventy | 1 |
| 451 | one-hundred-and-seventy-six | 1 |
| 452 | one-hundred-and-seventy-three | 1 |
| 453 | one-hundred-and-sixteen | 1 |
| 454 | one-hundred-and-sixty-two | 1 |
| 455 | one-hundred-and-thirty-seven | 1 |
| 456 | one-hundred-and-two | 1 |
| 457 | one-hundred-eighty | 1 |
| 458 | one-hundred-fifty | 1 |
| 459 | one-hundred-fifty-three | 1 |
| 460 | one-hundred-forty-nine | 1 |
| 461 | one-hundred-forty-one | 1 |
| 462 | one-hundred-forty-three | 1 |
| 463 | one-hundred-seventy-eight | 1 |
| 464 | one-hundred-six | 1 |
| 465 | one-hundred-sixteen | 1 |
| 466 | one-hundred-thirty-one | 1 |
| 467 | one-hundred-twenty | 1 |
| 468 | one-hundred-twenty-five | 1 |
| 469 | one-hundred-twenty-two | 1 |
| 470 | one-thousand-four-hundred-eleven | 1 |
| 471 | overall,100 | 1 |
| 472 | oxandrolone-treated | 1 |
| 473 | oxycodone-experienced | 1 |
| 474 | pain-adaptive | 1 |
| 475 | parent/adult | 1 |
| 476 | patients-206 | 1 |
| 477 | patifor | 1 |
| 478 | perimenopausal/early | 1 |
| 479 | persisent | 1 |
| 480 | petoralis | 1 |
| 481 | pnd-exposed | 1 |
| 482 | pneumoniae-seropositive | 1 |
| 483 | polmunate | 1 |
| 484 | posthemorrhoidectomy | 1 |
| 485 | ppoit-treated | 1 |
| 486 | prd-reduced | 1 |
| 487 | preflattened | 1 |
| 488 | prevention-group | 1 |
| 489 | prior-pci | 1 |
| 490 | prl-3-depleted | 1 |
| 491 | protocol-eligible | 1 |
| 492 | r5-virus-infected | 1 |
| 493 | reboxetine-treated | 1 |
| 494 | relapse-prone | 1 |
| 495 | repsox-treated | 1 |
| 496 | restrictive-rule-condition | 1 |
| 497 | ric-treated | 1 |
| 498 | rufinamide-treated | 1 |
| 499 | sarcosine-treated | 1 |
| 500 | seven-two | 1 |
| 501 | seventy-fi | 1 |
| 502 | sixtyone | 1 |
| 503 | still-sedated | 1 |
| 504 | subjects-559 | 1 |
| 505 | swiss-resident | 1 |
| 506 | sxity | 1 |
| 507 | t-dm1-treated | 1 |
| 508 | tamoxifen-naïve | 1 |
| 509 | tens-treated | 1 |
| 510 | teriflunomide-treated | 1 |
| 511 | therapy-compliant | 1 |
| 512 | thirtysix | 1 |
| 513 | thirtythree | 1 |
| 514 | three-hundred-and-fifty | 1 |
| 515 | three-hundred-and-ninety-seven | 1 |
| 516 | three-hundred-and-one | 1 |
| 517 | three-hundred-one | 1 |
| 518 | three-hundred-seventy-two | 1 |
| 519 | thriteen | 1 |
| 520 | thrity-two | 1 |
| 521 | tianeptine-treated | 1 |
| 522 | trimer-treated | 1 |
| 523 | trimodality-eligibile | 1 |
| 524 | truncally | 1 |
| 525 | turkey.all | 1 |
| 526 | tweenty | 1 |
| 527 | twent-two | 1 |
| 528 | twenty-5 | 1 |
| 529 | twenty-eight-day-old | 1 |
| 530 | twenty-five-bed | 1 |
| 531 | twenty-male | 1 |
| 532 | twenty-sevent | 1 |
| 533 | twentyfive | 1 |
| 534 | twentynine | 1 |
| 535 | twnety-seven | 1 |
| 536 | twnety-two | 1 |
| 537 | two-hundred-and-fifty | 1 |
| 538 | two-hundred-and-sixty | 1 |
| 539 | two-hundred-and-thirty-three | 1 |
| 540 | two-hundred-fifty | 1 |
| 541 | two-hundred-fifty-nine | 1 |
| 542 | two-hundred-nineteen | 1 |
| 543 | two-hundred-seventy-three | 1 |
| 544 | two-hundred-six | 1 |
| 545 | two-hundred-twenty-one | 1 |
| 546 | two-hundred-twenty-two | 1 |
| 547 | ubiquinone-10-in | 1 |
| 548 | underimmunized | 1 |
| 549 | unheavy | 1 |
| 550 | uninstitutionalized | 1 |
| 551 | vandetanib-treated | 1 |
| 552 | vorinostat-treated | 1 |
| 553 | vp-treated | 1 |
| 554 | vsd-operated | 1 |
| 555 | warfarin-ineligible | 1 |
| 556 | worry-prone | 1 |
| 557 | zanzibari | 1 |
| 558 | zidovudine-experienced | 1 |
| 1 | 'cloud | 1 |
| 2 | -eighty | 1 |
| 3 | 1,124,897 | 1 |
| 4 | 1,8-2,4 | 1 |
| 5 | 1,866,951 | 1 |
| 6 | 1,884 | 3 |
| 7 | 1,889 | 2 |
| 8 | 10,665 | 1 |
| 9 | 10,856 | 1 |
| 10 | 10.213 | 1 |
| 11 | 100/192 | 1 |
| 12 | 100/312 | 1 |
| 13 | 10096 | 1 |
| 14 | 11,436 | 1 |
| 15 | 11,452 | 1 |
| 16 | 11,849 | 1 |
| 17 | 11,962 | 1 |
| 18 | 116/120 | 1 |
| 19 | 117,411 | 1 |
| 20 | 119,573 | 1 |
| 21 | 12,636 | 1 |
| 22 | 12,842 | 1 |
| 23 | 123/261 | 1 |
| 24 | 126,092 | 1 |
| 25 | 13,272 | 1 |
| 26 | 135,967 | 1 |
| 27 | 14,270 | 1 |
| 28 | 14/381 | 1 |
| 29 | 142+/-28 | 1 |
| 30 | 146,095 | 1 |
| 31 | 149,893 | 1 |
| 32 | 15,263 | 1 |
| 33 | 15,336 | 1 |
| 34 | 15,694 | 1 |
| 35 | 16,397 | 1 |
| 36 | 167343 | 1 |
| 37 | 169/176 | 1 |
| 38 | 169/227 | 1 |
| 39 | 17,065 | 1 |
| 40 | 17o | 1 |
| 41 | 18,254 | 1 |
| 42 | 187/303 | 1 |
| 43 | 18790 | 1 |
| 44 | 19.409 | 1 |
| 45 | 191,167 | 1 |
| 46 | 1‒12-year-old | 1 |
| 47 | 2,067,639 | 1 |
| 48 | 2,295 | 2 |
| 49 | 2,770 | 1 |
| 50 | 2,951.95 | 1 |
| 51 | 2/5738 | 1 |
| 52 | 204,699 | 1 |
| 53 | 206/250 | 1 |
| 54 | 209/212 | 1 |
| 55 | 21,004 | 1 |
| 56 | 21,524 | 1 |
| 57 | 21,692 | 1 |
| 58 | 2121/2292 | 1 |
| 59 | 219,088 | 1 |
| 60 | 22,156 | 1 |
| 61 | 22,214 | 1 |
| 62 | 22,216 | 1 |
| 63 | 234,331 | 1 |
| 64 | 24,037 | 1 |
| 65 | 24,959 | 1 |
| 66 | 247,831 | 1 |
| 67 | 2489 | 4 |
| 68 | 25,180 | 1 |
| 69 | 253,238 | 1 |
| 70 | 254.78 | 1 |
| 71 | 2552 | 2 |
| 72 | 25:50:25 | 1 |
| 73 | 26/235 | 1 |
| 74 | 267/890 | 1 |
| 75 | 29,217 | 2 |
| 76 | 29.0-42.4 | 1 |
| 77 | 2fg | 2 |
| 78 | 2•8 | 1 |
| 79 | 3,633 | 1 |
| 80 | 3,809 | 1 |
| 81 | 3,855 | 2 |
| 82 | 30,528 | 1 |
| 83 | 30/244 | 1 |
| 84 | 30892 | 1 |
| 85 | 31,651 | 1 |
| 86 | 31,940 | 1 |
| 87 | 318/31 | 1 |
| 88 | 33,240 | 1 |
| 89 | 34,271 | 1 |
| 90 | 34/87 | 1 |
| 91 | 35,998 | 1 |
| 92 | 36,504 | 1 |
| 93 | 3824/4017 | 1 |
| 94 | 4-0.6 | 1 |
| 95 | 40/130 | 1 |
| 96 | 41/131 | 1 |
| 97 | 413-429 | 1 |
| 98 | 4154 | 2 |
| 99 | 42,382 | 1 |
| 100 | 42,411 | 1 |
| 101 | 43,1 | 1 |
| 102 | 4303 | 3 |
| 103 | 44.31 | 1 |
| 104 | 4429 | 1 |
| 105 | 46,685 | 1 |
| 106 | 46,769 | 1 |
| 107 | 47,369 | 2 |
| 108 | 47/130 | 1 |
| 109 | 471/666 | 1 |
| 110 | 476.29 | 1 |
| 111 | 478/1063 | 1 |
| 112 | 48,882 | 1 |
| 113 | 493,785 | 1 |
| 114 | 5,534 | 1 |
| 115 | 5-5 | 1 |
| 116 | 52,039 | 1 |
| 117 | 52,061 | 1 |
| 118 | 5294 | 1 |
| 119 | 53/57 | 1 |
| 120 | 5337 | 1 |
| 121 | 5377 | 2 |
| 122 | 54540 | 1 |
| 123 | 5461 | 1 |
| 124 | 57,432 | 1 |
| 125 | 5893 | 1 |
| 126 | 6,719 | 2 |
| 127 | 6,827 | 1 |
| 128 | 6,987 | 1 |
| 129 | 60/88 | 1 |
| 130 | 6162 | 3 |
| 131 | 63,251 | 1 |
| 132 | 63-wk-old | 1 |
| 133 | 6446 | 1 |
| 134 | 65,905 | 1 |
| 135 | 660/693 | 1 |
| 136 | 6698 | 2 |
| 137 | 6891 | 1 |
| 138 | 7,538 | 1 |
| 139 | 7,629 | 1 |
| 140 | 7,661 | 1 |
| 141 | 7,741 | 2 |
| 142 | 7021 | 2 |
| 143 | 7058 | 1 |
| 144 | 71,290 | 1 |
| 145 | 71,86 | 1 |
| 146 | 72,900 | 1 |
| 147 | 7487 | 1 |
| 148 | 75,242 | 1 |
| 149 | 75,589 | 1 |
| 150 | 7553 | 1 |
| 151 | 76,269 | 1 |
| 152 | 7601 | 3 |
| 153 | 7607 | 1 |
| 154 | 78+/-16 | 1 |
| 155 | 7830 | 1 |
| 156 | 8,210 | 1 |
| 157 | 8,817 | 1 |
| 158 | 8.0/13.3 | 1 |
| 159 | 8139 | 1 |
| 160 | 8181 | 2 |
| 161 | 8560 | 1 |
| 162 | 8688 | 1 |
| 163 | 890/2121 | 1 |
| 164 | 9,479 | 1 |
| 165 | 9,488 | 2 |
| 166 | 9,592 | 2 |
| 167 | 9,596 | 1 |
| 168 | 9274 | 1 |
| 169 | 9367 | 1 |
| 170 | 9408 | 1 |
| 171 | 9562 | 1 |
| 172 | a2-incompatible | 2 |
| 173 | ab103-treated | 1 |
| 174 | action-hf | 1 |
| 175 | ad-drug-naïve | 1 |
| 176 | adolescent/family | 1 |
| 177 | alvimopan-treated | 1 |
| 178 | among1036 | 1 |
| 179 | anastrozole-taking | 1 |
| 180 | anat | 5 |
| 181 | anatabine-treated | 1 |
| 182 | animals-211 | 1 |
| 183 | animals-29 | 1 |
| 184 | animals-74 | 1 |
| 185 | animals-84 | 1 |
| 186 | arbidole-treated | 1 |
| 187 | arvt-naive | 2 |
| 188 | aso-positive | 1 |
| 189 | b+e-treated | 1 |
| 190 | barangay | 1 |
| 191 | bardoxolone-methyl-treated | 1 |
| 192 | belimumab-treated | 2 |
| 193 | biflav | 1 |
| 194 | bk-viremic | 1 |
| 195 | blind-born | 1 |
| 196 | board-eligible/certified | 1 |
| 197 | bottom-integrated | 1 |
| 198 | brucella-negative | 1 |
| 199 | caelyx-treated | 1 |
| 200 | care-receiving | 1 |
| 201 | casein-treated | 1 |
| 202 | cbt-preferring | 1 |
| 203 | ce-dialyzed | 1 |
| 204 | chemotherapy-responding | 1 |
| 205 | chronotropically | 1 |
| 206 | cleaner-40 | 1 |
| 207 | clopidogrel-exposed | 1 |
| 208 | cohert | 1 |
| 209 | comparison-condition | 1 |
| 210 | conscription-aged | 1 |
| 211 | control-stented | 1 |
| 212 | control-supplemented | 1 |
| 213 | conventional-risk | 1 |
| 214 | cyclobenzaprine-treated | 1 |
| 215 | d350 | 1 |
| 216 | dawba-only | 1 |
| 217 | dc-vaccinated | 1 |
| 218 | dceas-treated | 1 |
| 219 | deferiprone-treated | 1 |
| 220 | dhea-deficient | 1 |
| 221 | diabesotensive | 1 |
| 222 | dissonance-intervention | 1 |
| 223 | dmt-naïve | 1 |
| 224 | do-not-intubate | 1 |
| 225 | drug-addicted | 3 |
| 226 | dual-pathology | 1 |
| 227 | early-colonised | 1 |
| 228 | egfr+/er- | 1 |
| 229 | eight-five | 4 |
| 230 | eight-four | 4 |
| 231 | eight-nine | 1 |
| 232 | eight-one | 5 |
| 233 | eight-seven | 1 |
| 234 | eight-six | 2 |
| 235 | eight-three | 2 |
| 236 | eighty | 1,355 |
| 237 | eighty-eight | 279 |
| 238 | eighty-five | 332 |
| 239 | eighty-four | 328 |
| 240 | eighty-nine | 231 |
| 241 | eighty-one | 306 |
| 242 | eighty-seven | 248 |
| 243 | eighty-six | 305 |
| 244 | eighty-three | 254 |
| 245 | eighty-two | 313 |
| 246 | eightyeight | 1 |
| 247 | eleven-week-old | 2 |
| 248 | english/spanish-speaking | 1 |
| 249 | enty | 1 |
| 250 | eqt-treated | 1 |
| 251 | er2/er3 | 1 |
| 252 | ercp-naïve | 1 |
| 253 | eswl-treated | 2 |
| 254 | ev68-positive | 1 |
| 255 | fcg-patient | 1 |
| 256 | ff7 | 1 |
| 257 | fifjty-two | 1 |
| 258 | fifteen-hundred | 1 |
| 259 | fifteen-month-old | 2 |
| 260 | fifty | 2,234 |
| 261 | fifty-eight | 424 |
| 262 | fifty-five | 469 |
| 263 | fifty-four | 531 |
| 264 | fifty-nine | 380 |
| 265 | fifty-one | 513 |
| 266 | fifty-seven | 375 |
| 267 | fifty-six | 496 |
| 268 | fifty-three | 435 |
| 269 | fifty-two | 630 |
| 270 | fiftynine | 2 |
| 271 | fiftyone | 1 |
| 272 | five-hundred-and-one | 1 |
| 273 | five/seven | 1 |
| 274 | forthy-three | 1 |
| 275 | forty | 2,727 |
| 276 | forty- | 2 |
| 277 | forty-eight | 806 |
| 278 | forty-five | 784 |
| 279 | forty-four | 675 |
| 280 | forty-nine | 457 |
| 281 | forty-one | 664 |
| 282 | forty-one-day-old | 1 |
| 283 | forty-seven | 486 |
| 284 | forty-seven-week-old | 1 |
| 285 | forty-six | 573 |
| 286 | forty-three | 582 |
| 287 | forty-two | 770 |
| 288 | forty-year-old | 1 |
| 289 | fortythree | 1 |
| 290 | four-hundred-and-forty-five | 1 |
| 291 | four-hundred-forty-nine | 1 |
| 292 | four-hundred-twenty-four | 1 |
| 293 | fourteen-week-old | 1 |
| 294 | fourthy-eight | 1 |
| 295 | fourty | 18 |
| 296 | fourty-five | 4 |
| 297 | fourty-four | 6 |
| 298 | fourty-nine | 6 |
| 299 | fourty-seven | 2 |
| 300 | fourty-six | 3 |
| 301 | fourty-three | 2 |
| 302 | fully-branded | 2 |
| 303 | ga-only | 1 |
| 304 | gnrh-deficient | 1 |
| 305 | grintuss® | 1 |
| 306 | guanqiao | 1 |
| 307 | head-restrained | 1 |
| 308 | high-pm | 1 |
| 309 | high-qor | 1 |
| 310 | high-testosterone | 2 |
| 311 | hiv/tb-coinfected | 1 |
| 312 | hmpv/rsv-coinfected | 1 |
| 313 | hospital-admitted | 1 |
| 314 | hour-to-hour | 1 |
| 315 | hundred-and-one | 1 |
| 316 | hypotonous | 1 |
| 317 | iai-treated | 1 |
| 318 | implant-assigned | 3 |
| 319 | industry-reported | 1 |
| 320 | intensive-group | 1 |
| 321 | interferon-beta-1b-treated | 1 |
| 322 | intervention-fifty-six | 1 |
| 323 | intradermally-vaccinated | 1 |
| 324 | inulin-supplemented | 1 |
| 325 | irinotecan-naïve | 1 |
| 326 | irinotecan-treated | 1 |
| 327 | itchy/burning | 1 |
| 328 | khalil | 1 |
| 329 | laiv-experienced | 1 |
| 330 | lanthanum-treated | 1 |
| 331 | ll/tt | 1 |
| 332 | lohman | 1 |
| 333 | low-fluoroscopy | 1 |
| 334 | low-readiness | 1 |
| 335 | lower-numeracy | 1 |
| 336 | lvt-treated | 1 |
| 337 | ly2140023-treated | 1 |
| 338 | ly2196044-treated | 1 |
| 339 | lycopercisi | 2 |
| 340 | maraviroc-receiving | 1 |
| 341 | med-assigned | 1 |
| 342 | medication-preferring | 2 |
| 343 | method-among | 1 |
| 344 | mhe-nl | 3 |
| 345 | milacemide-treated | 1 |
| 346 | moderate-cd/high-crp | 2 |
| 347 | more-disabled | 1 |
| 348 | mortalityin | 1 |
| 349 | mothod | 1 |
| 350 | n-acetylcysteine-assigned | 1 |
| 351 | nanohybrid-based | 1 |
| 352 | natamycintreated | 1 |
| 353 | neonaticide | 1 |
| 354 | never-hospitalized | 1 |
| 355 | niacin-er-treated | 1 |
| 356 | nighty | 1 |
| 357 | nine-hundred-ninety-one | 1 |
| 358 | nine-week-old | 1 |
| 359 | nineteeen | 3 |
| 360 | ninety | 950 |
| 361 | ninety-eight | 239 |
| 362 | ninety-five | 266 |
| 363 | ninety-four | 297 |
| 364 | ninety-nine | 216 |
| 365 | ninety-one | 265 |
| 366 | ninety-seven | 227 |
| 367 | ninety-six | 332 |
| 368 | ninety-three | 243 |
| 369 | ninety-two | 320 |
| 370 | ninteen | 1 |
| 371 | nintey-five | 1 |
| 372 | ninty | 9 |
| 373 | ninty-eight | 1 |
| 374 | ninty-seven | 3 |
| 375 | ninty-six | 4 |
| 376 | non-eating-disordered | 1 |
| 377 | non-european-born | 1 |
| 378 | non-hfi | 1 |
| 379 | nonabusing | 1 |
| 380 | nonhypersensitive | 1 |
| 381 | normotolerant | 1 |
| 382 | nsaid-using | 1 |
| 383 | octlar-treated | 1 |
| 384 | oligoasthenoteratospermic | 1 |
| 385 | on193 | 1 |
| 386 | one-hunderd-and-thirty-five | 1 |
| 387 | one-hundred- | 1 |
| 388 | one-hundred-and-eighty | 2 |
| 389 | one-hundred-and-fifty | 1 |
| 390 | one-hundred-and-fifty-seven | 1 |
| 391 | one-hundred-and-forty-nine | 1 |
| 392 | one-hundred-and-fourteen | 1 |
| 393 | one-hundred-and-one | 2 |
| 394 | one-hundred-and-seventeen | 1 |
| 395 | one-hundred-and-seventy | 1 |
| 396 | one-hundred-and-seventy-six | 1 |
| 397 | one-hundred-and-seventy-three | 1 |
| 398 | one-hundred-and-sixteen | 1 |
| 399 | one-hundred-and-sixty-two | 1 |
| 400 | one-hundred-and-ten | 2 |
| 401 | one-hundred-and-thirty-seven | 1 |
| 402 | one-hundred-and-twenty | 2 |
| 403 | one-hundred-and-two | 1 |
| 404 | one-hundred-eighty | 1 |
| 405 | one-hundred-fifty | 1 |
| 406 | one-hundred-fifty-three | 1 |
| 407 | one-hundred-forty | 3 |
| 408 | one-hundred-forty-nine | 1 |
| 409 | one-hundred-forty-one | 1 |
| 410 | one-hundred-forty-three | 1 |
| 411 | one-hundred-ninety | 3 |
| 412 | one-hundred-one | 2 |
| 413 | one-hundred-seventy-eight | 1 |
| 414 | one-hundred-six | 1 |
| 415 | one-hundred-sixteen | 1 |
| 416 | one-hundred-thirty-one | 1 |
| 417 | one-hundred-twenty | 1 |
| 418 | one-hundred-twenty-five | 1 |
| 419 | one-hundred-twenty-three | 2 |
| 420 | one-hundred-twenty-two | 1 |
| 421 | one-thousand-four-hundred-eleven | 1 |
| 422 | overall,100 | 1 |
| 423 | oxandrolone-treated | 1 |
| 424 | oxycodone-experienced | 1 |
| 425 | pain-adaptive | 1 |
| 426 | pain-vigilant | 2 |
| 427 | parent/adult | 1 |
| 428 | patients-206 | 1 |
| 429 | patifor | 1 |
| 430 | perimenopausal/early | 1 |
| 431 | permethrin-treated | 3 |
| 432 | persisent | 1 |
| 433 | petoralis | 1 |
| 434 | placebo-using | 5 |
| 435 | pnd-exposed | 1 |
| 436 | pneumoniae-seropositive | 1 |
| 437 | polmunate | 1 |
| 438 | posthemorrhoidectomy | 1 |
| 439 | ppoit-treated | 1 |
| 440 | prd-reduced | 1 |
| 441 | preflattened | 1 |
| 442 | prevention-group | 1 |
| 443 | prior-cabg | 2 |
| 444 | prior-pci | 1 |
| 445 | prl-3-depleted | 1 |
| 446 | protocol-eligible | 1 |
| 447 | r5-virus-infected | 1 |
| 448 | reboxetine-treated | 1 |
| 449 | relapse-prone | 1 |
| 450 | repsox-treated | 1 |
| 451 | restrictive-rule-condition | 1 |
| 452 | ric-treated | 1 |
| 453 | ris-lai-treated | 3 |
| 454 | rufinamide-treated | 1 |
| 455 | sarcosine-treated | 1 |
| 456 | scytalidium | 3 |
| 457 | seven-two | 1 |
| 458 | seven-week-old | 6 |
| 459 | seventy | 966 |
| 460 | seventy-eight | 291 |
| 461 | seventy-fi | 1 |
| 462 | seventy-five | 468 |
| 463 | seventy-four | 345 |
| 464 | seventy-nine | 310 |
| 465 | seventy-one | 336 |
| 466 | seventy-seven | 287 |
| 467 | seventy-six | 318 |
| 468 | seventy-three | 312 |
| 469 | seventy-two | 487 |
| 470 | sixty | 2,630 |
| 471 | sixty- | 5 |
| 472 | sixty-eight | 422 |
| 473 | sixty-five | 470 |
| 474 | sixty-four | 503 |
| 475 | sixty-nine | 319 |
| 476 | sixty-one | 441 |
| 477 | sixty-seven | 348 |
| 478 | sixty-six | 409 |
| 479 | sixty-three | 415 |
| 480 | sixty-two | 501 |
| 481 | sixtyone | 1 |
| 482 | still-sedated | 1 |
| 483 | subjects-559 | 1 |
| 484 | swiss-resident | 1 |
| 485 | sxity | 1 |
| 486 | t-dm1-treated | 1 |
| 487 | tamoxifen-naïve | 1 |
| 488 | tens-treated | 1 |
| 489 | teriflunomide-treated | 1 |
| 490 | thc-treated | 2 |
| 491 | therapy-compliant | 1 |
| 492 | thirteen-month-old | 2 |
| 493 | thirty | 3,249 |
| 494 | thirty- | 5 |
| 495 | thirty-eight | 672 |
| 496 | thirty-five | 746 |
| 497 | thirty-four | 739 |
| 498 | thirty-nine | 599 |
| 499 | thirty-one | 777 |
| 500 | thirty-seven | 580 |
| 501 | thirty-six | 946 |
| 502 | thirty-three | 684 |
| 503 | thirty-two | 984 |
| 504 | thirtyeight | 2 |
| 505 | thirtysix | 1 |
| 506 | thirtythree | 1 |
| 507 | three-hundred-and-fifty | 1 |
| 508 | three-hundred-and-ninety-seven | 1 |
| 509 | three-hundred-and-one | 1 |
| 510 | three-hundred-one | 1 |
| 511 | three-hundred-seventy-two | 1 |
| 512 | thriteen | 1 |
| 513 | thrity-two | 1 |
| 514 | tianeptine-treated | 1 |
| 515 | trimer-treated | 1 |
| 516 | trimodality-eligibile | 1 |
| 517 | truncally | 1 |
| 518 | turkey.all | 1 |
| 519 | tweenty | 1 |
| 520 | twent-two | 1 |
| 521 | twenty | 4,164 |
| 522 | twenty- | 3 |
| 523 | twenty-5 | 1 |
| 524 | twenty-bed | 2 |
| 525 | twenty-eight | 974 |
| 526 | twenty-eight-day-old | 1 |
| 527 | twenty-five-bed | 1 |
| 528 | twenty-male | 1 |
| 529 | twenty-sevent | 1 |
| 530 | twenty-six | 969 |
| 531 | twentyfive | 1 |
| 532 | twentynine | 1 |
| 533 | twnety-seven | 1 |
| 534 | twnety-two | 1 |
| 535 | two-hundred-and-fifty | 1 |
| 536 | two-hundred-and-sixty | 1 |
| 537 | two-hundred-and-thirty-three | 1 |
| 538 | two-hundred-fifty | 1 |
| 539 | two-hundred-fifty-nine | 1 |
| 540 | two-hundred-nineteen | 1 |
| 541 | two-hundred-seventy-three | 1 |
| 542 | two-hundred-six | 1 |
| 543 | two-hundred-twenty-one | 1 |
| 544 | two-hundred-twenty-two | 1 |
| 545 | ubiquinone-10-in | 1 |
| 546 | underimmunized | 1 |
| 547 | unheavy | 1 |
| 548 | uninstitutionalized | 1 |
| 549 | us-negative | 2 |
| 550 | vandetanib-treated | 1 |
| 551 | vilazodone-treated | 4 |
| 552 | vorinostat-treated | 1 |
| 553 | vp-treated | 1 |
| 554 | vsd-operated | 1 |
| 555 | warfarin-ineligible | 1 |
| 556 | worry-prone | 1 |
| 557 | zanzibari | 1 |
| 558 | zidovudine-experienced | 1 |
| 1 | one-hundred- | 1 |
| 2 | egfr+/er- | 1 |
| 3 | twenty- | 3 |
| 4 | thirty- | 5 |
| 5 | forty- | 2 |
| 6 | sixty- | 5 |
| 7 | overall,100 | 1 |
| 8 | 72,900 | 1 |
| 9 | 8,210 | 1 |
| 10 | 116/120 | 1 |
| 11 | 40/130 | 1 |
| 12 | 47/130 | 1 |
| 13 | 7830 | 1 |
| 14 | cleaner-40 | 1 |
| 15 | 33,240 | 1 |
| 16 | 54540 | 1 |
| 17 | 31,940 | 1 |
| 18 | 206/250 | 1 |
| 19 | d350 | 1 |
| 20 | 8560 | 1 |
| 21 | 14,270 | 1 |
| 22 | 2,770 | 1 |
| 23 | 25,180 | 1 |
| 24 | 71,290 | 1 |
| 25 | 18790 | 1 |
| 26 | 267/890 | 1 |
| 27 | 43,1 | 1 |
| 28 | 7601 | 3 |
| 29 | animals-211 | 1 |
| 30 | 42,411 | 1 |
| 31 | 117,411 | 1 |
| 32 | 7021 | 2 |
| 33 | 890/2121 | 1 |
| 34 | 44.31 | 1 |
| 35 | 318/31 | 1 |
| 36 | 41/131 | 1 |
| 37 | 234,331 | 1 |
| 38 | 247,831 | 1 |
| 39 | 7,741 | 2 |
| 40 | 63,251 | 1 |
| 41 | 31,651 | 1 |
| 42 | 1,866,951 | 1 |
| 43 | 52,061 | 1 |
| 44 | 123/261 | 1 |
| 45 | 5461 | 1 |
| 46 | 7,661 | 1 |
| 47 | 34,271 | 1 |
| 48 | 8181 | 2 |
| 49 | 14/381 | 1 |
| 50 | 6891 | 1 |
| 51 | 209/212 | 1 |
| 52 | 100/312 | 1 |
| 53 | 57,432 | 1 |
| 54 | 75,242 | 1 |
| 55 | 12,842 | 1 |
| 56 | 11,452 | 1 |
| 57 | 2552 | 2 |
| 58 | 6162 | 3 |
| 59 | 9562 | 1 |
| 60 | 11,962 | 1 |
| 61 | 13,272 | 1 |
| 62 | 42,382 | 1 |
| 63 | 48,882 | 1 |
| 64 | 126,092 | 1 |
| 65 | 100/192 | 1 |
| 66 | 2121/2292 | 1 |
| 67 | 9,592 | 2 |
| 68 | 21,692 | 1 |
| 69 | 30892 | 1 |
| 70 | 8.0/13.3 | 1 |
| 71 | 187/303 | 1 |
| 72 | 4303 | 3 |
| 73 | 10.213 | 1 |
| 74 | 3,633 | 1 |
| 75 | 167343 | 1 |
| 76 | 7553 | 1 |
| 77 | 478/1063 | 1 |
| 78 | 15,263 | 1 |
| 79 | 119,573 | 1 |
| 80 | on193 | 1 |
| 81 | 660/693 | 1 |
| 82 | 149,893 | 1 |
| 83 | 5893 | 1 |
| 84 | er2/er3 | 1 |
| 85 | 1,8-2,4 | 1 |
| 86 | 29.0-42.4 | 1 |
| 87 | 21,004 | 1 |
| 88 | 36,504 | 1 |
| 89 | 22,214 | 1 |
| 90 | 21,524 | 1 |
| 91 | 5,534 | 1 |
| 92 | 30/244 | 1 |
| 93 | 4154 | 2 |
| 94 | 18,254 | 1 |
| 95 | animals-74 | 1 |
| 96 | 9274 | 1 |
| 97 | animals-84 | 1 |
| 98 | 1,884 | 3 |
| 99 | 5294 | 1 |
| 100 | 15,694 | 1 |
| 101 | 5-5 | 1 |
| 102 | twenty-5 | 1 |
| 103 | 65,905 | 1 |
| 104 | 25:50:25 | 1 |
| 105 | 26/235 | 1 |
| 106 | 3,855 | 2 |
| 107 | 17,065 | 1 |
| 108 | 10,665 | 1 |
| 109 | 46,685 | 1 |
| 110 | 493,785 | 1 |
| 111 | 2,951.95 | 1 |
| 112 | 146,095 | 1 |
| 113 | 2,295 | 2 |
| 114 | 4-0.6 | 1 |
| 115 | patients-206 | 1 |
| 116 | 78+/-16 | 1 |
| 117 | 22,216 | 1 |
| 118 | among1036 | 1 |
| 119 | 15,336 | 1 |
| 120 | 11,436 | 1 |
| 121 | 12,636 | 1 |
| 122 | 6446 | 1 |
| 123 | 22,156 | 1 |
| 124 | 10,856 | 1 |
| 125 | 471/666 | 1 |
| 126 | 169/176 | 1 |
| 127 | 71,86 | 1 |
| 128 | 10096 | 1 |
| 129 | 9,596 | 1 |
| 130 | 7607 | 1 |
| 131 | 3824/4017 | 1 |
| 132 | 29,217 | 2 |
| 133 | 8,817 | 1 |
| 134 | 169/227 | 1 |
| 135 | 6,827 | 1 |
| 136 | 24,037 | 1 |
| 137 | 5337 | 1 |
| 138 | 53/57 | 1 |
| 139 | 191,167 | 1 |
| 140 | 9367 | 1 |
| 141 | 135,967 | 1 |
| 142 | 5377 | 2 |
| 143 | 34/87 | 1 |
| 144 | 7487 | 1 |
| 145 | 6,987 | 1 |
| 146 | 16,397 | 1 |
| 147 | 1,124,897 | 1 |
| 148 | ff7 | 1 |
| 149 | 9408 | 1 |
| 150 | 142+/-28 | 1 |
| 151 | 30,528 | 1 |
| 152 | 253,238 | 1 |
| 153 | 7,538 | 1 |
| 154 | 2/5738 | 1 |
| 155 | 7058 | 1 |
| 156 | 254.78 | 1 |
| 157 | 60/88 | 1 |
| 158 | 219,088 | 1 |
| 159 | 9,488 | 2 |
| 160 | 8688 | 1 |
| 161 | 6698 | 2 |
| 162 | 35,998 | 1 |
| 163 | 2•8 | 1 |
| 164 | 19.409 | 1 |
| 165 | 3,809 | 1 |
| 166 | 6,719 | 2 |
| 167 | animals-29 | 1 |
| 168 | 476.29 | 1 |
| 169 | 413-429 | 1 |
| 170 | 4429 | 1 |
| 171 | 7,629 | 1 |
| 172 | 52,039 | 1 |
| 173 | 8139 | 1 |
| 174 | 2,067,639 | 1 |
| 175 | 11,849 | 1 |
| 176 | subjects-559 | 1 |
| 177 | 24,959 | 1 |
| 178 | 76,269 | 1 |
| 179 | 47,369 | 2 |
| 180 | 46,769 | 1 |
| 181 | 9,479 | 1 |
| 182 | 2489 | 4 |
| 183 | 75,589 | 1 |
| 184 | 1,889 | 2 |
| 185 | 204,699 | 1 |
| 186 | bk-viremic | 1 |
| 187 | oligoasthenoteratospermic | 1 |
| 188 | twenty-five-bed | 1 |
| 189 | twenty-bed | 2 |
| 190 | zidovudine-experienced | 1 |
| 191 | oxycodone-experienced | 1 |
| 192 | laiv-experienced | 1 |
| 193 | prd-reduced | 1 |
| 194 | fully-branded | 2 |
| 195 | conscription-aged | 1 |
| 196 | board-eligible/certified | 1 |
| 197 | more-disabled | 1 |
| 198 | preflattened | 1 |
| 199 | med-assigned | 1 |
| 200 | n-acetylcysteine-assigned | 1 |
| 201 | implant-assigned | 3 |
| 202 | head-restrained | 1 |
| 203 | fifteen-hundred | 1 |
| 204 | non-eating-disordered | 1 |
| 205 | nanohybrid-based | 1 |
| 206 | early-colonised | 1 |
| 207 | pnd-exposed | 1 |
| 208 | clopidogrel-exposed | 1 |
| 209 | still-sedated | 1 |
| 210 | t-dm1-treated | 1 |
| 211 | ab103-treated | 1 |
| 212 | ly2140023-treated | 1 |
| 213 | ly2196044-treated | 1 |
| 214 | interferon-beta-1b-treated | 1 |
| 215 | belimumab-treated | 2 |
| 216 | vandetanib-treated | 1 |
| 217 | thc-treated | 2 |
| 218 | ric-treated | 1 |
| 219 | b+e-treated | 1 |
| 220 | rufinamide-treated | 1 |
| 221 | milacemide-treated | 1 |
| 222 | teriflunomide-treated | 1 |
| 223 | arbidole-treated | 1 |
| 224 | anatabine-treated | 1 |
| 225 | cyclobenzaprine-treated | 1 |
| 226 | sarcosine-treated | 1 |
| 227 | reboxetine-treated | 1 |
| 228 | tianeptine-treated | 1 |
| 229 | vilazodone-treated | 4 |
| 230 | oxandrolone-treated | 1 |
| 231 | deferiprone-treated | 1 |
| 232 | iai-treated | 1 |
| 233 | ris-lai-treated | 3 |
| 234 | eswl-treated | 2 |
| 235 | bardoxolone-methyl-treated | 1 |
| 236 | lanthanum-treated | 1 |
| 237 | irinotecan-treated | 1 |
| 238 | alvimopan-treated | 1 |
| 239 | casein-treated | 1 |
| 240 | permethrin-treated | 3 |
| 241 | vp-treated | 1 |
| 242 | octlar-treated | 1 |
| 243 | niacin-er-treated | 1 |
| 244 | trimer-treated | 1 |
| 245 | dceas-treated | 1 |
| 246 | tens-treated | 1 |
| 247 | vorinostat-treated | 1 |
| 248 | ppoit-treated | 1 |
| 249 | eqt-treated | 1 |
| 250 | lvt-treated | 1 |
| 251 | repsox-treated | 1 |
| 252 | caelyx-treated | 1 |
| 253 | natamycintreated | 1 |
| 254 | dc-vaccinated | 1 |
| 255 | intradermally-vaccinated | 1 |
| 256 | vsd-operated | 1 |
| 257 | bottom-integrated | 1 |
| 258 | r5-virus-infected | 1 |
| 259 | hiv/tb-coinfected | 1 |
| 260 | hmpv/rsv-coinfected | 1 |
| 261 | drug-addicted | 3 |
| 262 | prl-3-depleted | 1 |
| 263 | control-supplemented | 1 |
| 264 | inulin-supplemented | 1 |
| 265 | control-stented | 1 |
| 266 | industry-reported | 1 |
| 267 | hospital-admitted | 1 |
| 268 | uninstitutionalized | 1 |
| 269 | never-hospitalized | 1 |
| 270 | underimmunized | 1 |
| 271 | ce-dialyzed | 1 |
| 272 | fifteen-month-old | 2 |
| 273 | thirteen-month-old | 2 |
| 274 | nine-week-old | 1 |
| 275 | fourteen-week-old | 1 |
| 276 | eleven-week-old | 2 |
| 277 | seven-week-old | 6 |
| 278 | forty-seven-week-old | 1 |
| 279 | 63-wk-old | 1 |
| 280 | 1‒12-year-old | 1 |
| 281 | forty-year-old | 1 |
| 282 | forty-one-day-old | 1 |
| 283 | twenty-eight-day-old | 1 |
| 284 | mothod | 1 |
| 285 | 'cloud | 1 |
| 286 | neonaticide | 1 |
| 287 | eight-three | 2 |
| 288 | forthy-three | 1 |
| 289 | ninety-three | 243 |
| 290 | fifty-three | 435 |
| 291 | one-hundred-fifty-three | 1 |
| 292 | eighty-three | 254 |
| 293 | seventy-three | 312 |
| 294 | two-hundred-seventy-three | 1 |
| 295 | one-hundred-and-seventy-three | 1 |
| 296 | one-hundred-twenty-three | 2 |
| 297 | thirty-three | 684 |
| 298 | two-hundred-and-thirty-three | 1 |
| 299 | forty-three | 582 |
| 300 | one-hundred-forty-three | 1 |
| 301 | fourty-three | 2 |
| 302 | sixty-three | 415 |
| 303 | thirtythree | 1 |
| 304 | fortythree | 1 |
| 305 | twenty-male | 1 |
| 306 | protocol-eligible | 1 |
| 307 | warfarin-ineligible | 1 |
| 308 | a2-incompatible | 2 |
| 309 | trimodality-eligibile | 1 |
| 310 | eight-nine | 1 |
| 311 | ninety-nine | 216 |
| 312 | fifty-nine | 380 |
| 313 | two-hundred-fifty-nine | 1 |
| 314 | eighty-nine | 231 |
| 315 | seventy-nine | 310 |
| 316 | thirty-nine | 599 |
| 317 | forty-nine | 457 |
| 318 | one-hundred-forty-nine | 1 |
| 319 | four-hundred-forty-nine | 1 |
| 320 | one-hundred-and-forty-nine | 1 |
| 321 | fourty-nine | 6 |
| 322 | sixty-nine | 319 |
| 323 | fiftynine | 2 |
| 324 | twentynine | 1 |
| 325 | three-hundred-one | 1 |
| 326 | one-hundred-one | 2 |
| 327 | hundred-and-one | 1 |
| 328 | three-hundred-and-one | 1 |
| 329 | one-hundred-and-one | 2 |
| 330 | five-hundred-and-one | 1 |
| 331 | eight-one | 5 |
| 332 | ninety-one | 265 |
| 333 | nine-hundred-ninety-one | 1 |
| 334 | fifty-one | 513 |
| 335 | eighty-one | 306 |
| 336 | seventy-one | 336 |
| 337 | two-hundred-twenty-one | 1 |
| 338 | thirty-one | 777 |
| 339 | one-hundred-thirty-one | 1 |
| 340 | forty-one | 664 |
| 341 | one-hundred-forty-one | 1 |
| 342 | sixty-one | 441 |
| 343 | high-testosterone | 2 |
| 344 | relapse-prone | 1 |
| 345 | worry-prone | 1 |
| 346 | fiftyone | 1 |
| 347 | sixtyone | 1 |
| 348 | do-not-intubate | 1 |
| 349 | polmunate | 1 |
| 350 | arvt-naive | 2 |
| 351 | eight-five | 4 |
| 352 | nintey-five | 1 |
| 353 | ninety-five | 266 |
| 354 | fifty-five | 469 |
| 355 | eighty-five | 332 |
| 356 | seventy-five | 468 |
| 357 | one-hundred-twenty-five | 1 |
| 358 | thirty-five | 746 |
| 359 | one-hunderd-and-thirty-five | 1 |
| 360 | forty-five | 784 |
| 361 | four-hundred-and-forty-five | 1 |
| 362 | fourty-five | 4 |
| 363 | sixty-five | 470 |
| 364 | twentyfive | 1 |
| 365 | diabesotensive | 1 |
| 366 | brucella-negative | 1 |
| 367 | us-negative | 2 |
| 368 | nonhypersensitive | 1 |
| 369 | ev68-positive | 1 |
| 370 | aso-positive | 1 |
| 371 | pneumoniae-seropositive | 1 |
| 372 | pain-adaptive | 1 |
| 373 | ad-drug-naïve | 1 |
| 374 | irinotecan-naïve | 1 |
| 375 | tamoxifen-naïve | 1 |
| 376 | ercp-naïve | 1 |
| 377 | dmt-naïve | 1 |
| 378 | action-hf | 1 |
| 379 | prior-cabg | 2 |
| 380 | 2fg | 2 |
| 381 | chemotherapy-responding | 1 |
| 382 | english/spanish-speaking | 1 |
| 383 | anastrozole-taking | 1 |
| 384 | itchy/burning | 1 |
| 385 | medication-preferring | 2 |
| 386 | cbt-preferring | 1 |
| 387 | nsaid-using | 1 |
| 388 | placebo-using | 5 |
| 389 | nonabusing | 1 |
| 390 | maraviroc-receiving | 1 |
| 391 | care-receiving | 1 |
| 392 | method-among | 1 |
| 393 | prior-pci | 1 |
| 394 | seventy-fi | 1 |
| 395 | non-hfi | 1 |
| 396 | zanzibari | 1 |
| 397 | lycopercisi | 2 |
| 398 | conventional-risk | 1 |
| 399 | khalil | 1 |
| 400 | turkey.all | 1 |
| 401 | mhe-nl | 3 |
| 402 | high-pm | 1 |
| 403 | scytalidium | 3 |
| 404 | lohman | 1 |
| 405 | nineteeen | 3 |
| 406 | two-hundred-nineteen | 1 |
| 407 | thriteen | 1 |
| 408 | one-hundred-and-seventeen | 1 |
| 409 | ninteen | 1 |
| 410 | one-hundred-and-fourteen | 1 |
| 411 | one-hundred-sixteen | 1 |
| 412 | one-hundred-and-sixteen | 1 |
| 413 | one-hundred-and-ten | 2 |
| 414 | one-thousand-four-hundred-eleven | 1 |
| 415 | eight-seven | 1 |
| 416 | ninety-seven | 227 |
| 417 | three-hundred-and-ninety-seven | 1 |
| 418 | twnety-seven | 1 |
| 419 | fifty-seven | 375 |
| 420 | one-hundred-and-fifty-seven | 1 |
| 421 | eighty-seven | 248 |
| 422 | seventy-seven | 287 |
| 423 | ninty-seven | 3 |
| 424 | thirty-seven | 580 |
| 425 | one-hundred-and-thirty-seven | 1 |
| 426 | forty-seven | 486 |
| 427 | fourty-seven | 2 |
| 428 | sixty-seven | 348 |
| 429 | five/seven | 1 |
| 430 | ubiquinone-10-in | 1 |
| 431 | mortalityin | 1 |
| 432 | restrictive-rule-condition | 1 |
| 433 | comparison-condition | 1 |
| 434 | dissonance-intervention | 1 |
| 435 | blind-born | 1 |
| 436 | non-european-born | 1 |
| 437 | 17o | 1 |
| 438 | guanqiao | 1 |
| 439 | one-hundred-and-two | 1 |
| 440 | seven-two | 1 |
| 441 | twent-two | 1 |
| 442 | ninety-two | 320 |
| 443 | twnety-two | 1 |
| 444 | fifty-two | 630 |
| 445 | eighty-two | 313 |
| 446 | thrity-two | 1 |
| 447 | fifjty-two | 1 |
| 448 | seventy-two | 487 |
| 449 | three-hundred-seventy-two | 1 |
| 450 | one-hundred-twenty-two | 1 |
| 451 | two-hundred-twenty-two | 1 |
| 452 | thirty-two | 984 |
| 453 | forty-two | 770 |
| 454 | sixty-two | 501 |
| 455 | one-hundred-and-sixty-two | 1 |
| 456 | moderate-cd/high-crp | 2 |
| 457 | intensive-group | 1 |
| 458 | prevention-group | 1 |
| 459 | patifor | 1 |
| 460 | high-qor | 1 |
| 461 | eight-four | 4 |
| 462 | ninety-four | 297 |
| 463 | fifty-four | 531 |
| 464 | eighty-four | 328 |
| 465 | seventy-four | 345 |
| 466 | four-hundred-twenty-four | 1 |
| 467 | thirty-four | 739 |
| 468 | forty-four | 675 |
| 469 | fourty-four | 6 |
| 470 | sixty-four | 503 |
| 471 | hour-to-hour | 1 |
| 472 | petoralis | 1 |
| 473 | low-readiness | 1 |
| 474 | hypotonous | 1 |
| 475 | anat | 5 |
| 476 | fourthy-eight | 1 |
| 477 | ninety-eight | 239 |
| 478 | fifty-eight | 424 |
| 479 | eighty-eight | 279 |
| 480 | seventy-eight | 291 |
| 481 | one-hundred-seventy-eight | 1 |
| 482 | twenty-eight | 974 |
| 483 | ninty-eight | 1 |
| 484 | thirty-eight | 672 |
| 485 | forty-eight | 806 |
| 486 | sixty-eight | 422 |
| 487 | eightyeight | 1 |
| 488 | thirtyeight | 2 |
| 489 | parent/adult | 1 |
| 490 | therapy-compliant | 1 |
| 491 | pain-vigilant | 2 |
| 492 | normotolerant | 1 |
| 493 | swiss-resident | 1 |
| 494 | dhea-deficient | 1 |
| 495 | gnrh-deficient | 1 |
| 496 | fcg-patient | 1 |
| 497 | persisent | 1 |
| 498 | twenty-sevent | 1 |
| 499 | cohert | 1 |
| 500 | ll/tt | 1 |
| 501 | biflav | 1 |
| 502 | one-hundred-six | 1 |
| 503 | two-hundred-six | 1 |
| 504 | eight-six | 2 |
| 505 | ninety-six | 332 |
| 506 | fifty-six | 496 |
| 507 | intervention-fifty-six | 1 |
| 508 | eighty-six | 305 |
| 509 | seventy-six | 318 |
| 510 | one-hundred-and-seventy-six | 1 |
| 511 | twenty-six | 969 |
| 512 | ninty-six | 4 |
| 513 | thirty-six | 946 |
| 514 | forty-six | 573 |
| 515 | fourty-six | 3 |
| 516 | sixty-six | 409 |
| 517 | thirtysix | 1 |
| 518 | barangay | 1 |
| 519 | lower-numeracy | 1 |
| 520 | dual-pathology | 1 |
| 521 | adolescent/family | 1 |
| 522 | chronotropically | 1 |
| 523 | truncally | 1 |
| 524 | dawba-only | 1 |
| 525 | ga-only | 1 |
| 526 | perimenopausal/early | 1 |
| 527 | posthemorrhoidectomy | 1 |
| 528 | low-fluoroscopy | 1 |
| 529 | ninety | 950 |
| 530 | one-hundred-ninety | 3 |
| 531 | fifty | 2,234 |
| 532 | one-hundred-fifty | 1 |
| 533 | two-hundred-fifty | 1 |
| 534 | three-hundred-and-fifty | 1 |
| 535 | one-hundred-and-fifty | 1 |
| 536 | two-hundred-and-fifty | 1 |
| 537 | eighty | 1,355 |
| 538 | -eighty | 1 |
| 539 | one-hundred-eighty | 1 |
| 540 | one-hundred-and-eighty | 2 |
| 541 | nighty | 1 |
| 542 | sxity | 1 |
| 543 | enty | 1 |
| 544 | tweenty | 1 |
| 545 | seventy | 966 |
| 546 | one-hundred-and-seventy | 1 |
| 547 | twenty | 4,164 |
| 548 | one-hundred-twenty | 1 |
| 549 | one-hundred-and-twenty | 2 |
| 550 | ninty | 9 |
| 551 | thirty | 3,249 |
| 552 | forty | 2,727 |
| 553 | one-hundred-forty | 3 |
| 554 | fourty | 18 |
| 555 | sixty | 2,630 |
| 556 | two-hundred-and-sixty | 1 |
| 557 | unheavy | 1 |
| 558 | grintuss® | 1 |